Background
Nutrition is considered as an important therapeutic strategy modulating the meta bolic stress response and affecting the clinical outcome of critically ill patients. The use of early enteral nutrition (EN) should be preferred over parenteral nutri tion (PN) because it is more phy siologic and associated with improved outcome [14, 22] . EN is, however, frequently char acterized by a low caloric intake predomi nantly in the early phase of underlying disease [12, 25] . In order to improve en ergy delivery, an early supplemental use of PN is proposed [16] . The advantage of the one nutrition type is thereby regarded as the disadvantage of the other, as both have inherent risks of under or overfeed ing. On the one hand, large energy deficits resulting from a low caloric intake dur ing EN may lead to increased infectious complications and a longer intensive care unit (ICU) stay [10, 13, 35] . On the other hand, PN is associated with nutritional ex cess leading to hyperglycemia, increased meta bolic stress, and infectious morbi dity [9, 28] .
The guidelines of the European Society of Clinical Nutrition and Meta bolism ( ESPEN) and the American Society of Parenteral and Enteral Nutrition ( ASPEN) promote an early enteral start for nutri tion [23, 31] . In patients receiving less than their targeted enteral feeding after 2 days, ESPEN recommends to then initiate the use of supplemental PN to achieve the ca loric goal. ASPEN recommends retain ing supplemental PN until days 7-10, al lowing for a reduced caloric intake with EN alone unless the patient was previ ously malnourished. These guidelines are mainly based on nutritional data avail able from studies in mixed patient popula tions, while only few data exist for severe ly septic patients alone. Hence, the current Surviving Sepsis Campaign guidelines do not include specific nutritional recom mendations [8] , whereas the German Sepsis Society recommends the preferen tial use of early EN and the use of a com bination of EN and PN if caloric require ments cannot be sufficiently covered with a lowevidence grade E [5] . In a former prospective observational study of 415 pa tients with severe sepsis or septic shock, we found that the use of PN was associ ated with increased morbidity and mor tality [11] . Based on these former results, our present objective was to compare the outcomes of three nutritional strate gies (EN vs. PN vs. combined nutrition, i.e., EN+PN) in patients with severe sep sis or septic shock using the database of the " Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP)" trial [4] . In this analysis we only included patients with a length of ICU stay of more than 7 days to avoid the effect that patients with a short ICU stay receive less nutri tion and thus confound the effect on out come [3, 6, 18] .
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Methods
Study design and setting
This study was conducted as a secondary analysis of the VISEP trial, which was car ried out by the German Competence Net work Sepsis (SepNet) as a national, multi center, randomized study with a twoby two factorial design comparing intensive insulin therapy with conventional insu lin therapy and hydroxyethylstarch with Ringer's lactate for volume resuscitation. SepNet officially approved the use of the data from the VISEP trial. A detailed de scription of the original study design is outlined elsewhere [4] . Briefly, patients were recruited from April 2003 to June 2005 in multidisciplinary ICUs at 18 aca demic tertiary hospitals in Germany. The leading ethics committee of the Friedrich Schiller University of Jena and the re sponsible ethics committee at each par ticipating institution approved the study. All patients enrolled in the study had to fulfill the inclusion criteria for the pres ence of infection, systemic inflammatory response syndrome, and organ dysfunc tion or septic shock based on the consen sus criteria of the American College of Chest Physicians and Society of Critical Care Medicine [2] . Patients were deemed to be eligible if the onset of the syndrome was less than 24 h before or less than 12 h after admission to the ICU if the condi tion developed in the ICU, and they were followed up for 90 days to determine out come measures. All investigators agreed to base their patients' management on the international guidelines for the diagnosis and treatment of severe sepsis [33] . With respect to nutrition therapy, the preferen tial use of enteral nutrition was recom mended. In patients not tolerating EN despite the use of jejunal feeding or with contraindications to enteral nutrition, parenteral nutrition should be used.
For the present analysis we evaluated the nutrition data that were collected dai ly during the study period of up to 21 days or until death or discharge from the ICU.
Patients
The intentiontotreat population of the VISEP trial comprised 537 patients with severe sepsis or septic shock. We excluded patients with invalid data on nutrition from our analysis. As proposed by previ ous studies [3, 6, 18] , we further exclud ed patients with a length of ICU stay of 7 days or less in order to avoid potential confounding of a short ICU stay on the amount of nutrition therapy and outcome.
Patients were divided into groups according to the types of nutrition used in the VISEP trial, which were identified as exclusively EN, exclusively PN, and combined nutrition therapy (EN+PN). The latter involved all patients nour ished enterally and parenterally either on the same or different treatment days during the study period. Days without EN or PN were included and counted as 0 kcal. The patients' characteristics in cluding demographic data, Acute Physio logy and Chronic Health Evaluation II score (APACHE II score), and comor bidities were documented at the time of study entry. In surgical patients, the type of surgery (i.e., abdominal or gastrointes tinal surgery) suspected to influence the route of nutrition therapy was also iden tified at study entry. Data comprising the timing, route, and amount of nutrition, blood glucose, and insulin doses were col lected daily during the VISEP study peri od. The Harris-Benedict equation with out activity adjustment was used to calcu late the basal energy expenditure (BEE). The mean daily caloric intake was then divided by the BEE in order to estimate the ratio of caloric intake and energy ex penditure.
Per protocol, secondary infections were classified according to the onset (microbio logically proven or clinically suspected), origin (community acquired or nosocomial), and site of infection. This was determined by the investigator on site and required daily documentation throughout the study.
Outcome measures
Clinical outcome was measured by the Sequential Organ Failure Assessment (SOFA), the need for renalreplacement therapy, the duration of mechanical ven tilation, the incidence of severe hypogly cemia (≤40 mg of glucose per deciliter; 2.2 mmol per liter), length of ICU stay, secondary infections, and mortality.
Statistical analysis
Statistical analyses were performed us ing SAS software, version 9.1.3 (SAS In stitute Inc., Cary, NC, USA). Categori cal outcome data were reported as abso lute or relative frequencies and tested with the Chisquare test or Fisher's exact test, as appropriate. Continuous data were pre sented by mean and standard deviation or median and interquartile range and were compared using the ttest, ANOVA, Mann-Whitney U test, or Kruskall-Wal lis H test.
The rate of secondary infections and the length of stay in the ICU as well as mortality at 28 and 90 days were investi gated by the Kaplan-Meier method and tested by log rank test in an unadjusted fashion. Multiple Cox regression mod els were applied for adjusted analyses of time to event data. These analyses includ ed variables relevant for nutrition thera py or prognostic factors for patients with severe sepsis. Predictive factors with a p value <0.2 in the unadjusted model were included in the adjusted Cox regression model.
Twosided p values were reported and the level of significance was 0.05. Statis tical analyses followed the intentionto treat principle.
Results
Study population
A detailed flowchart of the study is given in . Fig. 1 . This study included 353 pa tients with severe sepsis or septic shock and length of ICU stay of more than 7 days with complete nutrition data collection.
Patient characteristics
. Tab. 1 summarizes the patient charac teristics by the different types of nutrition therapy. The majority of patients received EN+PN (n=242; 68.5%), whereof 233 pa tients were fed via the enteral and paren teral route on the same day and only 9 pa tients on different days. Patients in the EN and EN+PN groups were significantly older and had a higher APACHE II score compared to the patients receiving exclu sively PN. 
Nutrition therapy
Details on nutrition therapy and meta bolism are outlined in . Tab. 2. Median caloric intake and amount of protein were the highest for patients with EN+PN (1,343 kcal/day and 48.3 g/day, respective ly) and the lowest in the EN group (medi an 918 kcal/day and 33.6 g/day, p<0.001). Accordingly, this resulted in a significant ly higher ratio of mean daily caloric intake to calculated BEE by EN+PN (0.9; 0.7-1.1) than by EN (0.6; 0.4-0.9) or PN (0.8; 0.5-1.1, p<0.001). Median total duration of nu trition therapy in the ICU was 16 days and significantly longest with 18 days in pa tients receiving EN+PN compared to EN (14 days) and PN (8 days). Initiation of EN differed between EN (median day 1, IQR 0-1 days) and EN+PN (median day 3, IQR 1-5 days; p<0.001). No significant imbalances were found for the maximum and minimum blood glucose levels, while a trend toward higher insulin doses was found for PN and EN+PN.
. Fig. 2 shows the daily progres sion of caloric intake among the differ ent nutrition strategies during the study course and . Fig. 3 the daily proportion of calories administered by the enteral and parenteral route explicitly for patients with EN+PN. In this group, calories were predominantly administered by PN with in the first study week.
Outcomes
. Tab. 3 summarizes the clinical out comes. In patients with EN, the rate of renalreplacement therapy was signifi cantly lowest (20.9%, p=0.048) and the number of ventilatorfree days high est (median 4 days, p<0.001). These pa tients also had significantly fewer second ary infections on days 7 and 14 in the ICU (32.0 and 37.3%, p<0.001) and the lowest overall mortality on days 28 and 90 (12.8 and 26.7%, respectively, p=0.048).
. Fig. 4 provides Kaplan-Meier ana lyses for overall survival (part a) and the proportion of patients without secondary infections (part b) according to the three groups of nutrition therapy.
In the adjusted Cox regression ana lysis, EN+PN was associated with a higher mortality [adjusted hazard ra tio (HR)=1.86, 95% confidence interval (CI): 1.16-2.98, p=0.010] and a higher risk of secondary infections (HR=1.89 95% CI: 1.27-2.81, p=0.002) compared to EN (. Tab. 4). Due to the observed colinear ity of the route and amount of nutrition, we deli berately did not adjust for caloric or protein intake, respectively, in the Cox regression model.
Discussion
The present study evaluated nutrition therapy and clinical outcomes in a mixed medical and surgical population of 353 patients with severe sepsis or septic shock and a length of ICU stay of more than 7 days. In this highrisk subgroup of criti cally ill patients, we found that EN+PN was most frequently used with calories be ing administered early and predominant ly via the parenteral route within the first 7 study days. In comparison to this strat Mean ratios of daily caloric intake to BEE over the 21 study days in patients receiving enteral nutrition (EN, light gray bar), parenteral nutrition (PN, black bar), and combined enteral and parenteral nutrition (EN+PN, dark gray bar). Day 0 represents the time from randomization until the start of the next full 24-h study day; p values below the diagram indicate the significance of differences among the types of nutrition therapy per study day. The bars denote mean values ±2 standard error (SE) egy, patients who received EN alone, al beit resulting in a low calorie and protein intake according to current recommenda tions [23, 31] , had a lower mortality and lower morbidity as measured by the rate of infectious complications, renalreplace ment therapy, and ventilatorfree days.
The recent large randomizedcon trolled "Early Parenteral Nutrition Com pleting Enteral Nutrition in Adult Criti cally Ill Patients" (EPaNIC) trial com pared early (within 48 h) vs. late initia tion of PN (by day 8 after ICU admission) in combination with EN in a population of 4,640 mixed ICU patients [7] . The to tal study population comprised more than 60% cardiac surgery patients (22% with sepsis upon ICU admission) with a short median ICU stay of 3-4 days and a 90day mortality rate of only 11%. In the absence of a mortality effect, the late PN group had a shorter ICU and hospital stay, length of mechanical ventilation, and renalreplace ment therapy and fewer infectious com plications. Although the amount of calo ries administered was generally markedly lower in our study, both our EN+PN and their early initiation group were similar in terms of starting PN early (from day 1 on) and providing calories predominant ly via this route in combination with EN within the first 7 days. Our results sug gest that this approach is disadvantageous especially in the early disease phase of severely septic patients.
In contrast, previous observation al studies suggested a better outcome with increased caloric and protein intake owing to the early supplemental or pre dominant use of PN in critically ill pa tients [1, 10, 13, 27, 32, 35] . In the major ity of these studies, only a limited num ber of severely septic patients were includ ed. In a recent randomizedcontrolled tri al, Singer et al.
[30] evaluated whether nu trition therapy guided by repeated energy expenditure measurements (study group) as compared to protocolguided nutri tion prescription (25 kcal/kg/day, control group) improved outcome. Their study comprised 130 critically ill patients (22% with severe sepsis) with a minimum ICU stay of 3 days. A combination of EN and supplemental PN was used from study day 1 to reach the energy target in both groups. A trend toward lower hospital mortality was found in the study group, whereas the duration of mechanical ven tilation, the length of ICU stay, and the in fection rate were significantly increased. Compared to the control group, patients in the study group received more energy and protein because of more frequent use and a relatively higher daily proportion of supplemental PN. The reported increase in ventilation and ICU stay may simply be a function of an increased survival of the patients receiving PN, as no adjustment was made for ventilatorfree days or days in hospital but not in ICU. However, the Heidegger et al. and our study might be mainly explained by the different patient population studied and the time point of starting PN in combination with EN. We only included patients with severe sepsis and septic shock, which likely accounts for the generally higher mortality observed in our study (21% vs. 16% at 28 days). Unlike their SPN group where PN was delayed until day 4, patients in our EN+PN group received PN early in the course of sepsis from day 1 on. The negative effects of PN given as pri mary or supplementary therapy have been mainly linked to metabolic stress resulting from hyperalimentation with consecu tive hyperglycemia and increased infec tious complications, particularly during the early phase of critical illness [36] . In the presence of glycemic control, potential overfeeding might be indicated by meta bolic stress markers such as higher insu lin requirements, as suggested by previ ous studies [3, 11] . In our study, a trend to ward higher insulin doses was observed with EN+PN or PN, whereby the ran domized treatment arms (intensive and conventional insulin therapy) and the range of serum blood glucose (i.e., dai ly minimum and maximum values) were not significantly different, as was the rate of hypoglycemia.
Singer et al. [29] hypothesized that a transient metabolic shutdown is neces sary for cell survival during severe sep sis similar to a state of hibernation [24] .
According to this hypothesis it is likely that the energy requirements of our pa tients were markedly reduced since they were enrolled within the first 24 h after the onset of severe sepsis or septic shock. Kreyman et al. [19] showed that energy expenditure decreases with severity of ill ness resulting in prevailing hypometabo lism in patients with severe sepsis and sep tic shock. One may speculate that a low er caloric intake by EN especially in the early phase of illness could be sufficient to maintain basal metabolism for survival and prevent metabolic stress.
The adverse outcome of the patients with EN+PN may also be explained by complications unrelated to hyperglyce mia. In septic patients, the use of PN was associated with an increased risk of liver dysfunction [15] while lowdose enter al nutrition maintained the gastric mu cosal balance and improved systemic and hepatosplanchnic blood flow [26] . PN may exhibit considerable hazard when given to patients with a functioning gas trointestinal tract, and this may have ap plied to 55.3% of the surgical patients with EN+PN who had no history of abdomi nal surgery present at study entry. On the contrary, the remaining patients with EN+PN were admitted with a history of abdominal surgery, implying that the de cision of combined feeding was based on the presence of gastrointestinal dysfunc tion. In such patients with gastrointesti nal dysfunction, Kutsogiannis et al. re cently demonstrated that both early and late supplemental PN were still found to be associated with worsening outcomes in an observational study of 2,920 critically ill patients (9% with sepsis) [21] .
In the absence of a standardized nu trition protocol, not only the caloric in take but also the median protein intake in our study population was generally low according to current recommendations for protein administration in critically ill patients [20, 31] . It remains uncertain to what extent this has affected our results. However, the optimal goal of protein ad ministration and possible impact on the inflammatory response in patients with severe sepsis still remains unknown and has not been addressed by randomized controlled trials so far. In a retrospective study of 295 patients (34% with sepsis) re maining in the ICU for more than 7 days, Tsai et al. did not find differences in clini cal outcomes with respect to protein deliv ery [34] . Neither did the very large obser vational study by Kutsogiannis et al., de spite an improved delivery of 80% of the prescribed protein intake with supple mental PN [21] .
Limitations
The main limitation is the design of our study. We are unable to imply causality to the association found because residual confounding due to inhomogeneous pa tient characteristics among the nutrition groups may still exist despite the adjust ment for various covariates. Only a ran domizedcontrolled trial of severely sep tic patients designed to separate the effects of the different route and amount of nutri tion may corroborate our hypothesisgen erating results. Owing to the low number of patients receiving PN only, the analy sis lacks in power for the comparison of EN vs. PN and EN+PN vs. PN. We there fore focused on the comparison of EN and EN+PN, but presented data on PN for the sake of completeness.
A further limitation is that no stan dardized nutrition protocol was specifi cally followed in the study but investiga tors agreed to base their patients' manage ment on the international guidelines for the diagnosis and treatment of severe sep sis [33] . This included the preferential use of EN as well as using PN for those pa tients intolerant to EN or with contraindi cations. Our study also lacks more detailed information on the specific formulations used including supplementary immunon utrition and administration of prokinetics in the different groups. Moreover, actual energy expenditure was not measured by indirect calorimetry but only calculated using the Harris-Benedict equation. This static approach only estimates the patient's metabolic activity, and current guidelines [23, 31] recommend the routine use of in direct calorimetry albeit this technique is not commonly available in many ICUs. Initiation of EN differed between patients with EN and EN+PN, which might have influenced our results. However, Cahill et al. were able to show that even late EN alone (>48 h), as compared to either late (>48 h) or early (<48 h) supplemental PN, tended to decrease mortality in medical ICU patients with an ICU stay longer than 3 days [6] . Finally, the patients' nutritional status before study entry was only charac terized by the BMI at study entry that was in the range of 23-30 kg/m 2 . We acknow ledge that our results may not apply to se verely septic patients with preexisting pro teinenergy malnutrition or obesity, who might profit from a daily increased energy and protein administration [1] .
The strength of our study is the focus on a large study population of patients with severe sepsis or septic shock remain ing at least 7 days in the ICU and that the data on nutrition therapy were prospec tively collected for up to 21 ICU days.
Conclusion
F This secondary analysis of the VISEP trial revealed that the early and predominant use of parenteral nutrition combined with enteral nutrition resulted in a higher caloric intake in patients with severe sepsis and septic shock and prolonged ICU stay compared to early enteral nutrition alone. F However, the use of enteral nutrition alone was associated with improved outcome in this specific subgroup of critically ill patients. F These hypothesis-generating results have to be confirmed by a randomized-controlled trial in a homogeneous patient population of only severely septic patients. 
